Terns Pharmaceuticals's total assets for Q1 2025 were $339.31M, a decrease of -6.76% from the previous quarter. TERN total liabilities were $13.27M for the fiscal quarter, a -26.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.